Healthcare | November 16, 2022
Experts highlight the rising cases of diabetes in youngsters
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Man lost 54 Kgs in 6 months with MGB procedure
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
To address the preventive & primary healthcare delivery gaps in India
Tirzepatide is primarily indicated for the treatment of T2D and is expected to receive its decision from the FDA in Q2 2022
In clinical trials, treatment proved more effective than other therapies evaluated
India has the second-largest number of adults with diabetes globally, after China
Subscribe To Our Newsletter & Stay Updated
